OOIR: Observatory of International Research

Papers

(The TQCC of Best Practice & Research Clinical Endocrinology & Metabolism is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Editorial Board	105
Editorial Board	82
Editorial Board	79
Surgery for prolactinoma	72
Growth hormone replacement in adults with cured acromegaly: Efficacy and safety	69
Thiazide-induced hyponatremia	67
Gonadectomy in individuals with a difference of sex development – For whom, when, why, and why not?	59
Treatment of acromegaly with the nonpeptide, highly selective somatostatin receptor type 2 agonist paltusotine	58
Recent progress in molecular classification of phaeochromocytoma and paraganglioma	46
The role of androgens in transgender medicine	44
Sexual health and contraception in the menopause journey	42
Coronavirus disease 2019 and vitamin D	39
Polygenic risk scores for dyslipidemia and atherosclerotic cardiovascular disease: Progress toward clinical implementation	39
Editorial Board	37
Haematological actions of androgens	36
Impulse control disorders and dopamine agonists	36
Cardiometabolic outcomes of early onset hypogonadism in males	34
Editorial Board	34
Remnant lipoprotein particles and cardiovascular disease risk	29
Optimal surgical approach for digestive neuroendocrine neoplasia primaries: Oncological benefits versus short and long-term complications	28
Metabolic complications and their mechanisms in patients with craniopharyngioma	27
Radioiodine therapy in the different stages of differentiated thyroid cancer	27
Editorial Board	27
Molecular basis of symptomatic sporadic primary hyperparathyroidism: New frontiers in pathogenesis	26
Epidemiology and risk factors for hypopituitarism due to traumatic brain injury	26

Acquired disorders of phosphaturia: Beyond tumor-induced osteomalacia	25
Safety of long-term use of daily and long-acting growth hormone in growth hormone-deficient adults on cancer risk	25
Pathogenic role of Th17 cells in autoimmune thyroid disease and their underlying mechanisms	25
Non-oestrogen-based and complementary therapies for menopause	24
Approach to patients with elevated low-density lipoprotein cholesterol levels	23
Medullary thyroid cancer - An update	23
Pathophysiology of thyroid-associated orbitopathy	23
Editorial Board	22
Best practice and research clinical endocrinology and metabolism issue on phaeochromocytomas and paragangliomas	22
Best Practice and Research Clinical Endocrinology and Metabolism focusing on Growth Hormone Deficiency in Adults – New Perspectives	22
Personalized management for phaeochromocytomas and paragangliomas in Latin America: A genetic perspective	21
Editorial Board	21
Hyponatraemic encephalopathy	20
Localization in primary hyperparathyroidism	20
Pathophysiology and diagnosis of neuroendocrine abnormalities in patients with traumatic brain injury	20
Safety of androgen therapy in men with prostate cancer	20
Genotype-phenotype correlations in Graves’ disease	19
Editorial Board	19
Post cancer care in women with an increased risk of malignancy or previous malignancy: The use of hormone replacement therapy and alternative treatments	19
Hyponatremia and bone pathophysiology: An integrated preclinical and clinical perspective	19
Recent advances in algorithms predicting hemodynamic instability undergoing surgery for phaeochromocytoma and paraganglioma	19
Editorial Board	18
Diagnostic algorithm of hyponatremia	18
Preconception use of GLP-1 and GLP-1/GIP receptor agonists for obesity treatment	17
Mortality in craniopharyngiomas: Data from the last two decades	17
Type 5 diabetes: A disorder associated with undernutrition: The epidemiology, pathogenesis, clinical features and differential diagnosis	17
Multiple endocrine neoplasia type 2: From molecular genetics to precision therapy	17
Diagnosis and treatment of hypernatremia	16
Care quality improvement in differences of sex development	16
Surgical outcomes in patients with acromegaly: Microscopic vs. endoscopic transsphenoidal surgery	16
Preface	16
The options for delayed surgery – Is there evidence available for delayed genitoplasty in differences/disorders of sex development?	15
COVID-induced thyroid autoimmunity	15
Best practice & research clinical endocrinology & metabolism focusing on the menopause – Diagnostic and therapeutic strategies	15
Anaplastic thyroid cancer: An update	14
Hormone replacement in disorders of sex development, and long-term effects	14
Chemokines in thyroid autoimmunity	14
Editorial Board	14
“Micromegaly”: Acromegaly with apparently normal GH, an entity on its own?	14
Best practice & research clinical endocrinology & metabolism prolactinoma	13
Ectopic craniopharyngiomas	13
Genetic endocrine tumours focusing on pituitary tumours	13
Preface	13
Outcomes of pregnancies complicated by type 2 diabetes	13
The epidemiology of disorders of sex development	12
Treatments of psychiatric disorders, hyperprolactinemia and dopamine agonists	12
The interplay between thyrotropic axis, neurological complications, and rehabilitation outcomes in patients with traumatic brain injury	12
Editorial Board	12
Addressing the social determinants of adverse outcomes in pregestational diabetes	12
Strategies for improving the knowledge of patients and carers	12

Covid-19 and endocrinology